Nitric oxide-modulating biomaterials for therapeutic Immunoengineering
Advanced Drug Delivery Reviews · 2025-12 · 227 · 115718
DOI: 10.1016/j.addr.2025.115718 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Drug Delivery Reviews, 2025-12. Verfasst von Yeonju Boo und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Repu…. Hauptthemen laut MEDLINE: Nitric Oxide, Biocompatible Materials. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 402 Literaturangaben. Gefördert von: Korea Ministry of Science and ICT, National Research Foundation of Korea, Korea Health Industry Development Institute.
Abstract (Originalsprache)
Nitric oxide (NO) plays dual and context-dependent roles in the immune system, functioning as either an immunostimulatory or immunosuppressive mediator depending on its concentration, cellular source, and exposure dynamics. Dysregulated endogenous NO production is implicated in the pathogenesis of a broad spectrum of diseases. Therapeutic modulation of NO levels via engineered delivery systems represents a promising approach for immune regulation. This review provides a comprehensive overview of NO-modulating biomaterials, with a focus on two opposing strategies: NO scavenging to remove pathologically excessive NO and NO delivery to restore physiologically essential NO levels. We first examined the distinct molecular mechanisms and cell type-specific effects of endogenous and exogenous NO, highlighting its pleiotropic immunoregulatory roles in macrophages, dendritic cells, T cells, B cells, neutrophils, and myeloid-derived suppressor cells. We then classify representative NO scavengers and NO donors according to their chemical structures and activation triggers, including pH, redox, enzyme, and stimulus-responsive systems. Next, we discuss the design and application of advanced biomaterial-based platforms that integrate these agents into immunoengineering interventions for various disease models. Finally, we address the key translational challenges and design principles required to achieve precise, spatiotemporally controlled, and disease-selective NO modulation. Collectively, this review summarizes recent advances in NO-regulating biomaterials and highlights their potential to reprogram immune responses for therapeutic benefit.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea.
- School of Integrative Engineering, Chung-Ang University, Seoul 06974, Republic of Korea.
- School of Integrative Engineering, Chung-Ang University, Seoul 06974, Republic of Korea. Electronic address: jihoonkim@cau.ac.kr.
- Department of Chemistry, POSTECH-CATHOLIC Biomedical Engineering Institute, Pohang University of Science and Technology (POSTECH), Pohang 37673, Republic of Korea; OmniaMed Co, Ltd., Pohang 37673, Republic of Korea. Ele…
Förderung
- Korea Ministry of Science and ICT
- National Research Foundation of Korea
- Korea Health Industry Development Institute
- Korea Ministry of Health and Welfare
Zitieren
APA
Boo, Y., Choi, S. H., Kim, J., & Kim, W. J. (2025). Nitric oxide-modulating biomaterials for therapeutic Immunoengineering. Advanced Drug Delivery Reviews, 227, 115718. https://doi.org/10.1016/j.addr.2025.115718
Vancouver
Boo Y, Choi SH, Kim J, Kim WJ. Nitric oxide-modulating biomaterials for therapeutic Immunoengineering. Advanced Drug Delivery Reviews. 2025;227:115718. doi:10.1016/j.addr.2025.115718
BibTeX
@article{Boo2025,
author = {Boo, Yeonju and Choi, Sang-Hun and Kim, Jihoon and Kim, Won Jong},
title = {Nitric oxide-modulating biomaterials for therapeutic Immunoengineering},
journal = {Advanced Drug Delivery Reviews},
year = {2025},
volume = {227},
pages = {115718},
doi = {10.1016/j.addr.2025.115718}
}
EUVIMED